Albemarle CorpChange company Symbol lookupSelect an option...ALB Albemarle CorpFDCFF Forum Energy Metals CorpAFMD Affimed NVARVN Arvinas IncFOUR Shift4 Payments IncUK Ucommune International LtdCRDF Cardiff Oncology IncTRNR Interactive Strength IncOMGA Omega Therapeutics IncACST Acasti Pharma IncGo
Change company Symbol lookup
Select an option...
ALB Albemarle Corp
FDCFF Forum Energy Metals Corp
AFMD Affimed NV
ARVN Arvinas Inc
FOUR Shift4 Payments Inc
UK Ucommune International Ltd
CRDF Cardiff Oncology Inc
TRNR Interactive Strength Inc
OMGA Omega Therapeutics Inc
ACST Acasti Pharma Inc
Materials : Chemicals | Mid Cap Blend
Company profileAlbemarle Corporation is a global developer, manufacturer and marketer of specialty chemicals. The Company operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage business contributes to the growth of clean miles driven with electric vehicles and more efficient use of renewable energy through grid storage. Its Specialties segment enables the prevention of fires starting in electronic equipment, greater fuel efficiency from rubber tires and the reduction of emissions from coal-fired power plants. The Ketjen business creates efficiency of natural resources through more usable products from a single barrel of oil, enables safer, greener production of alkylates used to produce more environmentally friendly fuels, and reduced emissions through cleaner transportation fuels. It serves the markets, such as serve include energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals and crop protection.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
| Latest Earnings Beat Consensus (Q2 ending 06/2023) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced August 2, 2023 | $7.33 | Q2 Consensus of 18 analysts | $4.44 | Difference from consensus | 65.20% | Q3 Earnings will announce | (Unconfirmed) October 31, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
ALB's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.